Rebus Holdings, Inc.
OTC: RBSH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Raul Silvestre
- Employees
- 1
- Headquarters
- Westlake Village, United States
- IPO year
- 2009
- Market cap
- $3.2K
- Website
- https://www.rebus-corp.com
Loading RBSH…
Loading profile data…Frequently asked questions about RBSH
What does Rebus Holdings, Inc. (RBSH) do?
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was esta...
Where does RBSH trade?
Rebus Holdings, Inc. (RBSH) trades on the Other OTC.
What sector is RBSH in?
Rebus Holdings, Inc. (RBSH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Rebus Holdings, Inc.?
Raul Silvestre is the chief executive officer of Rebus Holdings, Inc. (RBSH).
Where is Rebus Holdings, Inc. headquartered?
Rebus Holdings, Inc. is headquartered in United States.
Does RBSH pay a dividend?
Rebus Holdings, Inc. (RBSH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RBSH go public?
Rebus Holdings, Inc. (RBSH) completed its initial public offering in 2009.